SMAD3 and lung carcinoma: USP7 promotes positive self-regulation of SMAD3 by catalysing SMAD3 deubiquitination and inhibits the progression of p53-deficient lung cancer, suggesting that SMAD3 can play an anti-cancer role in lung cancer [95].